摘要
目的:观察低分子肝素治疗不稳定型心绞痛疗效。方法:选择诊断明确的不稳型心绞痛患者62例,随机分为治疗组(32例)和对照组(30例),对照组采用硝酸酯制剂、β受体阻滞剂、钙道阻滞剂、肠溶阿司匹林等常规药物治疗,治疗组在以上治疗的基础上加用低分子肝素,观察两组对心绞痛的疗效。结果:治疗组临床症状明显改善,心电图缺血性ST段下移明显改善,且优于对照组,P均<0．05。结论:低分子肝素治疗不稳定型心绞痛疗效肯定,安全,优于常规抗心绞痛治疗。
Objective： To investigate the effect of low molecular weight heparin on unstable angina pectoris （UAP）. Methods： Sixty-two patients with UAP were divided randomly into treatment group （32 cases） and control group （30 cases）. The patients in control group were treated with the routine therapy of angina pectoris. The patients in treatment group were added with low molecular weight heparin besides the routine therapy of angina pectoris. Results ：Compared with the control, the clinical symptoms and ST depression of electrocardiogram （ECG） were improved in treatment group （P〈0.05, all）. Conclusion： Low molecular weight heparin in treatment of UAP is more effective and safety than the routine therapy of angina pectoris.
出处
《心血管康复医学杂志》
CAS
2006年第1期51-53,共3页
Chinese Journal of Cardiovascular Rehabilitation Medicine
关键词
心绞痛
不稳定型
肝素
低分子量
治疗结果
Angina, unstable
Heparin, low molecular weight
Therapeutic result
